Elixinol Wellness Ltd (ASX: EXL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Elixinol Wellness Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$4.55 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
413.99 million
Earnings per share
-0.003
Dividend per share
N/A
Year To Date Return
22.22%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Elixinol Wellness Ltd (ASX: EXL)
Latest News
Retail Shares
Soft spending: How ASX retail shares are responding to a weak month
Cannabis Shares
Blazing it? How the top ASX cannabis shares performed in FY21
Cannabis Shares
Elixinol (ASX:EXL) share price heats up on cannabis business update
Cannabis Shares
Here's why ASX cannabis shares are lighting up today
Share Market News
Why ASX hemp share Elixinol's (ASX:EXL) share price is moving higher
Share Market News
Why the Elixinol (ASX:EXL) share price has been halted today?
Share Market News
Up in smoke! Why ASX cannabis shares are having a bleary day
Share Fallers
Why Elixinol Global, Flight Centre, Mesoblast, & WiseTech shares are dropping lower
Share Market News
Why the Elixinol Global (ASX:EXL) share price is getting smoked today
Share Market News
27 ASX companies just got an unwanted knock on the door
Share Market News
Elixinol (ASX:EXL) share price tumbles on capital raising update
Share Market News
Why the Elixinol (ASX:EXL) share price popped 43% today
EXL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Elixinol Wellness Ltd
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries. It derives maximum revenue from Australia.
EXL Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 15 Jan 2026 | $0.01 | $0.00 | 0.00% | 235 | $0.01 | $0.01 | $0.01 |
| 13 Jan 2026 | $0.01 | $0.00 | 0.00% | 352,424 | $0.01 | $0.01 | $0.01 |
| 12 Jan 2026 | $0.01 | $0.00 | 0.00% | 1,147,578 | $0.01 | $0.01 | $0.01 |
| 09 Jan 2026 | $0.01 | $0.00 | 0.00% | 42,051 | $0.01 | $0.01 | $0.01 |
| 08 Jan 2026 | $0.01 | $0.00 | 0.00% | 912,587 | $0.01 | $0.01 | $0.01 |
| 07 Jan 2026 | $0.01 | $0.00 | 0.00% | 180,000 | $0.01 | $0.01 | $0.01 |
| 06 Jan 2026 | $0.01 | $0.00 | 0.00% | 5,422,864 | $0.01 | $0.01 | $0.01 |
| 05 Jan 2026 | $0.01 | $0.00 | 0.00% | 20,613 | $0.01 | $0.01 | $0.01 |
| 02 Jan 2026 | $0.01 | $0.00 | 0.00% | 126 | $0.01 | $0.01 | $0.01 |
| 31 Dec 2025 | $0.01 | $0.00 | 0.00% | 439,666 | $0.01 | $0.01 | $0.01 |
| 30 Dec 2025 | $0.01 | $0.00 | 0.00% | 265,100 | $0.01 | $0.01 | $0.01 |
| 29 Dec 2025 | $0.01 | $0.00 | 0.00% | 5,139 | $0.01 | $0.01 | $0.01 |
| 24 Dec 2025 | $0.01 | $0.00 | 0.00% | 101,276 | $0.01 | $0.01 | $0.01 |
| 23 Dec 2025 | $0.01 | $0.00 | 0.00% | 25,099 | $0.01 | $0.01 | $0.01 |
| 22 Dec 2025 | $0.01 | $0.00 | 0.00% | 233,691 | $0.01 | $0.01 | $0.01 |
| 19 Dec 2025 | $0.01 | $0.00 | 0.00% | 6,357,163 | $0.01 | $0.01 | $0.01 |
| 18 Dec 2025 | $0.01 | $0.00 | 0.00% | 1,131,875 | $0.01 | $0.01 | $0.01 |
| 17 Dec 2025 | $0.01 | $0.00 | 0.00% | 3,537,455 | $0.01 | $0.01 | $0.01 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 30 Dec 2025 | Gavin Evans | Buy | 397,010 | $3,820 |
On-market trade.
|
| 27 Jun 2025 | Natalie Butler | Exercise | 36,417 | $400 |
Conversion of securities. 36,417 Performance Rights
|
| 27 Jun 2025 | Natalie Butler | Issued | 36,417 | $400 |
Conversion of securities.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Ms Pauline Therese Gately | Non-Executive Director | Aug 2023 |
Ms Gately is a director who brings a commercial focus to strategy in funding, business development, and strategic transformation having led companies through IPO, business recalibration and mergers and acquisitions. Her Board contributions are also underpinned by senior roles in international investment banking across the Asia Pacific region. She is Chair of the Risk Committee.
|
| Ms Natalie Butler | Head of MarketingExecutive Director | Mar 2024 |
Ms Butler over a decade of strategic marketing leadership to the table, Natalie has a proven history of growth and innovation on both local and global brands. Having worked closely with the Sustainable Nutrition Group marketing and product teams over the past year, she is uniquely positioned to spearhead future growth opportunities for the Group. As General Manager of Tom Organic, Natalie steered the company to success and direct major global initiatives with renowned brands within the L'Oreal Group.
|
| Mr Gavin Evans | Non-Executive ChairmanNon-Executive Director | Dec 2025 |
Mr Gavin has experience in building profitable, vertically integrated food and wellness
businesses, having founded Openway Food Co and led multiple growth platforms..He has recently been supporting the Company as a Strategic Adviser and brings deep capability across execution, M&A, brand building and supply-chain optimisation, along with strong industry relationships that will support Elixinol's continued transformation and path to profitability. |
| Ms Melanie Jaye Leydin | Company Secretary | Jul 2024 |
-
|
| Melanie Jaye Leydin | Company Secretary |
-
|
|
| Josephine Lorenz | Group Chief Financial Officer |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Freedom Trader Pty Ltd | 14,692,194 | 6.65% |
| Mr Stuart Reseck & Mrs Nicole Deanne Reseck (Reseck Super Fund A/C) | 13,333,334 | 6.04% |
| Cutter Super Pty Ltd (Cutter Sf A/C) | 12,500,000 | 5.66% |
| HSBC Custody Nominees (Australia) Limited | 10,047,366 | 4.55% |
| Cg Nominees (Australia) Pty Ltd | 9,574,074 | 4.34% |
| UBS Nominees Pty Ltd | 7,838,694 | 3.55% |
| 10 Bolivianos Pty Ltd | 6,011,427 | 2.72% |
| G & A Eshuys Superannuation Pty Ltd (G & A Eshuys S/F A/C) | 4,318,665 | 1.96% |
| Gidgell Pty Ltd (The Jay-Em A/C) | 4,256,887 | 1.93% |
| BNP Paribas Noms Pty Ltd | 4,228,987 | 1.92% |
| Rosedale Super Pty Ltd (Rosedale Super Fund A/C) | 3,343,022 | 1.51% |
| Citicorp Nominees Pty Limited | 2,386,228 | 1.08% |
| Jasforce Pty Ltd (Alex Waislitz Retire A/C) | 2,306,551 | 1.04% |
| Ms Pauline Therese Gately | 2,296,671 | 1.04% |
| Capital Accretion Pty Ltd (The Fortified Value A/C) | 2,233,798 | 1.01% |
| Interdale Pty Ltd (Maple Super A/C) | 2,157,888 | 0.98% |
| Raw With Life Pty Ltd (Benhaim Trading A/C) | 2,111,611 | 0.96% |
| Mr David John Fenlon | 1,563,381 | 0.71% |
| Mr Kieran John O'Brien | 1,562,500 | 0.71% |
| A&N Mcintosh Holdings Pty Ltd (Tiger Investment A/C) | 1,551,196 | 0.70% |
